Some patients with peripheral arterial disease may present with critical limb ischemia, a condition associated with high rates of morbidity and mortality. Early diagnosis and effective medical therapy and revascularization are indicated to avoid amputation and reduce mortality. Ideally, a multidisciplinary approach with collaboration between endovascular interventionist, vascular surgeons, podiatrist, infectious disease, and wound care specialist is recommended for these patients.
HirschATHaskalZJHertzerNR. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654.
2.
NorgrenLHiattWRDormandyJA. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67.
3.
AdamDJBradburyAW. TASC II document on the management of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2007;33(1):1–2.
4.
State-specific smoking-attributable mortality and years of potential life lost—United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2009;58(2):29–33.
5.
BaigentCBlackwellLCollinsR. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860.
6.
JhaPJacobBGajalakshmiV. A nationally representative case-control study of smoking and death in India. N Engl J Med. 2008;358(11):1137–1147.
7.
ParaskevasKIHamiltonGMikhailidisDPLiapisCD. Optimal medical management of peripheral arterial disease. Vasc Endovasc Surg. 2007;41(1):87.
8.
DormandyJARutherfordRB.Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 Pt 2):S1–S296.
9.
CatalanoM. Epidemiology of critical limb ischaemia: north Italian data. Eur J Med. 1993;2(1):11–14.
10.
FosseSHartemann-HeurtierAJacqueminetS. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med. 2009;26(4):391–396.
11.
JensenSAVattenLJMyhreHO. The prevalence of chronic critical lower limb ischaemia in a population of 20,000 subjects 40-69 years of age. Eur J Vasc Endovasc Surg. 2006;32(1):60–65.
12.
RajagopalanSGrossmanPM. Management of chronic critical limb ischemia. Cardiol Clin. 2002;20(4):535–545.
13.
Van HattumESTangelderMJLawsonJAMollFLAlgraA.Long-term risk of vascular events after peripheral bypass surgery. A cohort study. Thromb Haemost. 2012;108(3):543–553.
14.
TangGLChangDSSarkarRWangRMessinaLM. The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. J Vasc Surg. 2005;41(2):312–320.
15.
CoatsPWadsworthR. Marriage of resistance and conduit arteries breeds critical limb ischemia. Am J Physiol Heart Circ Physiol. 2005;288(3):H1044–H1050.
16.
MarstonWADaviesSWArmstrongB. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006;44(1):108–114.
17.
PercivalTJRasmussenTE. Reperfusion strategies in the management of extremity vascular injury with ischaemia. Br J Surg. 2012;99(suppl 1):66–74.
18.
MorelSKwakBR. Roles of connexins in atherosclerosis and ischemia-reperfusion injury. Curr Pharm Biotechnol. 2012;13(1):17–26.
19.
BraunersreutherVJaquetV. Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr Pharm Biotechnol. 2012;13(1):97–114.
20.
GillaniSCaoJSuzukiTHakDJ. The effect of ischemia reperfusion injury on skeletal muscle. Injury. 2012;43(6):670–675.
KersteinMD. The non-healing leg ulcer: peripheral vascular disease, chronic venous insufficiency, and ischemic vasculitis. Ostomy Wound Manage. 1996;42(10A suppl):19S–35S.
23.
TreimanGSCoplandSMcNamaraRM. Factors influencing ulcer healing in patients with combined arterial and venous insufficiency. J Vasc Surg. 2001;33(6):1158–1164.
24.
NevilleRFAttingerCEBulanEJ. Revascularization of a specific angiosome for limb salvage: does the target artery matter?Ann Vasc Surg. 2009;23(3):367–373.
25.
TaylorGIPalmerJH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg. 1987;40(2):113–141.
26.
AttingerCEEvansKKBulanEBlumePCooperP.Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg. 2006;117(7 suppl):261S–293S.
27.
IidaONantoSUematsuM. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010;75(6):830–836.
28.
TaylorGIPanWR.Angiosomes of the leg: anatomic study and clinical implications. Plast Reconstr Surg. 1998;102(3):599–616; discussion 617-598.
29.
FowkesFGMurrayGDButcherI. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.
30.
ParaskevasKIGiannoukasADKotsikorisIMikhailidisDP. Contrast-induced nephropathy and the vascular patient. Angiology. 2010;61(8):721–723.
31.
PerrinTDescombesECookS. Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly. 2012;142:w13608.
32.
CollinsRBurchJCrannyG. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007;334(7606):1257.
33.
LoweryAJHynesNManningBJ. A prospective feasibility study of duplex ultrasound arterial mapping, digital-subtraction angiography, and magnetic resonance angiography in management of critical lower limb ischemia by endovascular revascularization. Ann Vasc Surg. 2007;21(4):443–451.
34.
CollinsRArmitageJParishSSleighPPetoR. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361(9374):2005–2016.
35.
BhattDLFoxKAHackeW. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706–1717.
36.
CacoubPPBhattDLStegPGTopolEJCreagerMA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J. 2009;30(2):192–201.
37.
ManciaGDe BackerGDominiczakA. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462–1536.
38.
YusufSSleightPPogueJ. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145–153.
39.
YusufSTeoKKPogueJ. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547–1559.
40.
RadackKDeckC.Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med. 1991;151(9):1769–1776.
41.
ParaskevasKIMikhailidisDPVeithFJ. Optimal statin type and dosage for vascular patients. J Vasc Surg. 2011;53(3):837–844.
42.
ParaskevasKIVeithFJLiapisCDMikhailidisDP.Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update [published online January 20, 2012]. Curr Vasc Pharmacol.
43.
Alonso-CoelloPBellmuntSMcGorrianC. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e669S–e690S.
44.
SchanzerAHeveloneNOwensCD. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg. 2008;47(4):774–781.
45.
KannelWB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1(4):333–339.
46.
VirkkunenJHeikkinenMLepantaloMMetsanojaRSaleniusJP. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg. 2004;40(4):761–767.
47.
BrassEPAnthonyRDormandyJ. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg. 2006;43(4):752–759.
48.
RuffoloAJRomanoMCiapponiA.Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev. 2010;(1):CD006544.
49.
NorgrenLAlwmarkAAngqvistKA. A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study. Eur J Vasc Surg. 1990;4(5):463–467.
50.
UbbinkDTVermeulenH. Spinal cord stimulation for critical leg ischemia: a review of effectiveness and optimal patient selection. J Pain Symptom Manage. 2006;31(4 suppl):S30–S35.
51.
AdamDJBeardJDClevelandT. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934.
52.
TongersJRoncalliJGLosordoDW. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation. 2008;118(1):9–16.
53.
NicolaidesANBreddinHKCarpenterP. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol. 2005;24(1):1–26.
54.
RutherfordRBBakerJDErnstC. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–538.
55.
HynesBGMargeyRJRuggieroN 2nd. Endovascular management of acute limb ischemia. Ann Vasc Surg. 2012;26(1):110–124.
56.
JafferyZThorntonSNWhiteCJ. Acute limb ischemia. Am J Med Sci. 2011;342(3):226–234.
